Arrowhead Pharmaceuticals (HDP1.XETRA) Q3 2026 Earnings

4AugConfirmed
Q2 2026
Next
-1.12
-1.01
-0.9
-0.79

Details

Expected EPS
-1.1187432921
Actual EPS
N/A
Surprise EPS
1.12
Surprise Percent
+100%

Description

Arrowhead Pharmaceuticals (HDP1.XETRA) will report earnings of for Q3 2026 on August 04, 2026.

0 Comments

Share your thoughts